Metal-based nanoparticle interactions with the nervous system: The challenge of brain entry and the risk of retention in the organism

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 5, Issue 4, 2013, Pages 346-373

  Yokel, Robert ^a   Grulke, Eric ^b   Macphail, Robert ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD-BRAIN BARRIER; BRAIN PARENCHYMA; DORSAL ROOT GANGLION CELLS; ENVIRONMENTAL FACTORS; LITERATURE SEARCH; NANOPARTICLE INTERACTION; NANOPARTICLE UPTAKES; SYSTEM RESPONSE;

BLOOD; CELLS; COLLOID CHEMISTRY; CYTOLOGY; METALS;

METAL NANOPARTICLES;

GOLD NANOPARTICLE; METAL NANOPARTICLE;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; COLLOID; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ENVIRONMENTAL FACTOR; HUMAN; NANOMEDICINE; NERVOUS SYSTEM; NEUROANATOMY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT; SPINAL GANGLION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; ENVIRONMENT; HUMANS; METAL NANOPARTICLES; REPRODUCIBILITY OF RESULTS; TISSUE DISTRIBUTION;

EID: 84879196737     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1202     Document Type: Article

References (196)

1. Riviere JE. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:26-34.
2. MacPhail RC, Grulke EA, Yokel RA. Assessing nanoparticle risk poses prodigious challenges. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012. Submitted for publication.
3. Weller RO, Djuanda E, Yow H-Y, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 2009, 117:1-14.
4. Muldoon LL, Varallyay P, Kraemer DF, Kiwic G, Pinkston K, Walker-Rosenfeld SL, Neuwelt EA. Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat. Neuropathol Appl Neurobiol 2004, 30:70-79.
5. Verkhratsky A, Butt A, eds. Glial Neurobiology. Chichester, England: Wiley; 2007.
6. Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, Jacob Filho W, Lent R, Herculano-Houzel S. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain. J Comp Neurol 2009, 513:532-541.
7. Sherwood CC, Stimpson CD, Raghanti MA, Wildman DE, Uddin M, Grossman LI, Goodman M, Redmond JC, Bonar CJ, Erwin JM, et al. Evolution of increased glia-neuron ratios in the human frontal cortex. Proc Natl Acad Sci U S A 2006, 103:13606-13611.
8. Abitz M, Nielsen RD, Jones EG, Laursen H, Graem N, Pakkenberg B. Excess of neurons in the human newborn mediodorsal thalamus compared with that of the adult. Cereb Cortex 2007, 17:2573-2578.
9. Kandel E, Schwartz J, Jessell T, Siegelbaum S, Hudspeth AJ. Principles of Neural Science. New York: McGraw-Hill Ryerson; vol. 5. 2012.
10. Rippel RA, Seifalian AM. Gold revolution-gold nanoparticles for modern medicine and surgery. J Nanosci Nanotechnol 2011, 11:3740-3748.
11. Eastman J. Colloid stability. In: Cosgrove T, ed. Colloid science - Principles, Methods and Applications. Hoboken, NJ: Blackwell Publishing; 2005, 36-49.
12. Leaver J. Protein adsorption on latex particles. In: Schwarz JA, Contescu CI, eds. Surfaces of Nanoparticles and Porous Materials. New York: Marcel Dekker; 1999, 743-762.
13. Somasundaran P, Markovic B, Krishnakumar S, Yu X. Colloid systems and interfaces - stability of dispersion through polymer and surfactant adsorption. In: Birdi KS, ed. Handbook of Surface and Colloid Chemistry. Boca Raton: CRC Press; 1997, 155-196.
14. De TK, Maitra A. Particle engineering of drug-loaded nanoparticles and their potential drug-targeting applications. In: Birdi KS, ed. Handbook of Surface and Colloid Chemistry, 2nd ed. Boca Raton: CRC Press; 2002.
15. Pochan DJ, Zhu J, Zhang K, Wooley KL, Miesch C, Emrick T. Multicompartment and multigeometry nanoparticle assembly. Soft Matter 2011, 7:2500-2506.
16. Lee M-Y, Park S-J, Park K, Kim KS, Lee H, Hahn SK. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex. ACS Nano 2011, 5:6138-6147.
17. Liu Y, Sun J, Han J, He Z. Long-circulating targeted nanoparticles for cancer therapy. Curr Nanosci 2010, 6:347-354.
18. Cho W-S, Cho M-J, Jeong J-Y, Choi M-N, Han B-S, Shin H-S, Hong J, Chung B-H, Jeong J-Y, Cho M-H. Size-dependent tissue kinetics of PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2010, 245:116-123.
19. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A 1993, 90:10957-10961.
20. Santos RR, Vermeulen S, Haritova A, Fink-Gremmels J. Isotherm modeling of organic activated bentonite and humic acid polymer used as mycotoxin adsorbents. Food Addit Contam, Part A 2011, 28:1578-1589.
21. Hongo M, Ohara S, Hirasawa Y, Abe S, Asaki S, Toyota T. Effect of lansoprazole on intragastric pH. Comparison between morning and evening dosing. Dig Dis Sci 1992, 37:882-890.
22. Fallingborg J, Christensen LA, Jacobsen BA, Ingeman-Nielsen M, Rasmussen HH, Abildgaard K, Rasmussen SN. Effect of olsalazine and mesalazine on intraluminal pH of the duodenum and proximal jejunum in healthy humans. Scand J Gastroenterol 1994, 29:498-500.
23. Bergstrom CA, Luthman K, Artursson P. Accuracy of calculated pH-dependent aqueous drug solubility. Eur J Pharm Sci 2004, 22:387-398.
24. Zarate N, Mohammed SD, O'Shaughnessy E, Newell M, Yazaki E, Williams NS, Lunniss PJ, Semler JR, Scott SM. Accurate localization of a fall in pH within the ileocecal region: validation using a dual-scintigraphic technique. Am J Physiol Gastrointest Liver Physiol 2010, 299:G1276-G1286.
25. Chesler M. Regulation and modulation of pH in the brain. Physiol Rev 2003, 83:1183-1221.
26. Scott CC, Gruenberg J. Ion flux and the function of endosomes and lysosomes: pH is just the start. Bioessays 2011, 33:103-110.
27. Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm 2011, 8:2032-2038.
28. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
29. Garza-Ocanas L, Ferrer DA, Burt J, Diaz-Torres LA, Ramirez Cabrera M, Rodriguez VT, Lujan Rangel R, Romanovicz D, Jose-Yacaman M. Biodistribution and long-term fate of silver nanoparticles functionalized with bovine serum albumin in rats. Metallomics 2010, 2:204-210.
30. Deng X, Luan Q, Chen W, Wang Y, Wu M, Zhang H, Jiao Z. Nanosized zinc oxide particles induce neural stem cell apoptosis. Nanotechnology 2009, 20:115101.
31. Lin CH, Chang LW, Chang H, Yang MH, Yang CS, Lai WH, Chang WH, Lin P. The chemical fate of the Cd/Se/Te-based quantum dot 705 in the biological system: toxicity implications. Nanotechnology 2009, doi:20:215101/1-215101/9.
32. Wankhede M, Bouras A, Kaluzova M, Hadjipanayis CG. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol 2012, 5:173-186.
33. Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 2007, 81:53-60.
34. Ghosh S, Ghosh MS, Cai T, Diercks DR, Mills NC, Hynds DL. Alternating magnetic field controlled, multifunctional nano-reservoirs: intracellular uptake and improved biocompatibility. Nanoscale Res Lett 2010, 5:195-204.
35. Celardo I, Traversa E, Ghibelli L. Cerium oxide nanoparticles; a promise for applications in therapy. J Exp Ther Oncol 2011, 9:47-51.
36. Neuwelt EA, Varallyay P, Bago AG, Muldoon LL, Nesbit G, Nixon R. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumours. Neuropathol Appl Neurobiol 2004, 30:456-471.
37. Neuwelt EA, Varallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, et al. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study (discussion). Neurosurgery 2007, 60:601-611.
38. Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol 2011, 103:317-324.
39. Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001, 90:1927-1936.
40. Monteiro-Riviere NA, Filon FL. Skin. In: Fadeel BP, Pietroiusti A, Shvedova AA, eds. Adverse Effects of Engineered Nanomaterials. Missouri: Elsevier; 2012, 185-207.
41. Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
42. Ohno K, Pettigrew KD, Rapoport SI. Lower limits of cerebrovascular permeability to nonelectrolytes in the conscious rat. Am J Physiol 1978, 235:H299-H307.
43. Bondy SC. Nanoparticles and colloids as contributing factors in neurodegenerative disease. Int J Environ Res Public Health 2011, 8:2200-2211.
44. Tsai PS, Kaufhold JP, Blinder P, Friedman B, Drew PJ, Karten HJ, Lyden PD, Kleinfeld D. Correlations of neuronal and microvascular densities in murine cortex revealed by direct counting and colocalization of nuclei and vessels. J Neurosci 2009, 29:14553-14570.
45. Vorbrodt AW. Ultracytochemical characterization of anionic sites in the wall of brain capillaries. J Neurocytol 1989, 18:359-368.
46. Georgieva JV, Kalicharan D, Couraud P-O, Romero IA, Weksler B, Hoekstra D, Zuhorn IS. Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood-brain barrier endothelial cells in vitro. Mol Ther 2011, 19:318-325.
47. Tang J, Xiong L, Zhou G, Wang S, Wang J, Liu L, Li J, Yuan F, Lu S, Wan Z, et al. Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro. J Nanosci Nanotechnol 2010, 10:6313-6317.
48. Dan M, Tseng MT, Wu P, Unrine JM, Grulke EA, Yokel RA. Brain microvascular endothelial cell association and distribution of a 5 nm ceria engineered nanomateria. Int J Nanomed 2012, 7:4023-4036.
49. Rapoport SI. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert Opin Investig Drugs 2001, 10:1809-1818.
50. Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, Jolesz FA, Sheikov N. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 2006, 105:445-454.
51. Liu H-L, Hua M-Y, Yang H-W, Huang C-Y, Chu P-C, Wu J-S, Tseng IC, Wang J-J, Yen T-C, Chen P-Y, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A 2010, 107:15205-15210. doi:S15205/15201-S15205/15207.
52. Takeda K, Suzuki K-i, Ishihara A, Kubo-Irie M, Fujimoto R, Tabata M, Oshio S, Nihei Y, Ihara T, Sugamata M. Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. J Health Sci 2009, 55:95-102.
53. Hunter DD, Undem BJ. Identification and substance P content of vagal afferent neurons innervating the epithelium of the guinea pig trachea. Am J Respir Crit Care Med 1999, 159:1943-1948.
54. Estevanato L, Cintra D, Baldini N, Portilho F, Barbosa L, Martins O, Lacava B, Miranda-Vilela AL, Tedesco AC, Bao S, et al. Preliminary biocompatibility investigation of magnetic albumin nanosphere designed as a potential versatile drug delivery system. Int J Nanomedicine 2011, 6:1709-1717.
55. Cambianica I, Bossi M, Gasco P, Gonzalez W, Idee JM, Miserocchi G, Rigolio R, Chanana M, Morjan I, Wang D, et al. Targeting cells with MR imaging probes: Cellular interaction and intracellular magnetic iron oxide nanoparticles uptake in brain capillary endothelial and choroidal plexus epithelial cells. AIP Conf Proc 2010, 1275:145-149.
56. 59Fe-activated track-autoradiography. J Trace Microprobe Tech 1998, 16:523-534.
57. Nau R, Soergel F, Eiffert H. Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 2010, 23:858-883.
58. Felgenhauer K. Protein filtration and secretion at human body fluid barriers. Pfluegers Arch 1980, 384:9-17.
59. Yokel RA, Au TC, MacPhail R, Hardas SS, Butterfield DA, Sultana R, Tseng MT, Dan M, Florence RL, Unrine JM, et al. Distribution, elimination and biopersistence to 90 days of a systemically-introduced 30 nm ceria engineered nanomaterial in rats. Toxicol Sci 2012, 127:256-268.
60. de Lorenzo AJD. The olfactory neuron and the blood-brain barrier. In: Wolstenholme G, Knight J, eds. Taste and Smell in Vertebrates. London: Churchhill; 1970, 151-176.
61. Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Kreyling W, Cox C. Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 2004, 16:437-445.
62. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, Potter R, Maynard A, Ito Y, Finkelstein J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006, 114:1172-1178.
63. Gao X, Chen J, Chen J, Wu B, Chen H, Jiang X. Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging. Bioconjug Chem 2008, 19:2189-2195.
64. Yu LE, Yung L-YL, Ong C-N, Tan Y-L, Balasubramaniam KS, Hartono D, Shui G, Wenk MR, Ong W-Y. Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotoxicology 2007, 1:235-242.
65. Sung JH, Ji JH, Park JD, Song MY, Song KS, Ryu HR, Yoon JU, Jeon KS, Jeong J, Han BS, et al. Subchronic inhalation toxicity of gold nanoparticles. Part Fibre Toxicol 2011, 8:16.
66. 2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett 2008, 183:72-80.
67. 2 nanoparticles. Toxicology 2008, 254:82-90.
68. Wang B, Feng W, Zhu M, Wang Y, Wang M, Gu Y, Ouyang H, Wang H, Li M, Zhao Y, et al. Neurotoxicity of low-dose repeatedly intranasal instillation of nano- and submicron-sized ferric oxide particles in mice. J Nanopart Res 2009, 11:41-53.
69. Wang Y, Wang B, Zhu MT, Li M, Wang HJ, Wang M, Ouyang H, Chai ZF, Feng WY, Zhao YL. Microglial activation, recruitment and phagocytosis as linked phenomena in ferric oxide nanoparticle exposure. Toxicol Lett 2011, 205:26-37.
70. Lalancette-Hebert M, Moquin A, Choi AO, Kriz J, Maysinger D. Lipopolysaccharide-QD micelles induce marked induction of TLR2 and lipid droplet accumulation in olfactory bulb microglia. Mol Pharm 2010, 7:1183-1194.
71. Hutter E, Boridy S, Labrecque S, Lalancette-Hebert M, Kriz J, Winnik FM, Maysinger D. Microglial response to gold nanoparticles. ACS Nano 2010, 4:2595-2606.
72. Liu Y, Guan W, Ren G, Yang Z. The possible mechanism of silver nanoparticle impact on hippocampal synaptic plasticity and spatial cognition in rats. Toxicol Lett 2012, 209:227-231.
73. Garcia GJM, Kimbell JS. Deposition of inhaled nanoparticles in the rat nasal passages: dose to the olfactory region. Inhal Toxicol 2009, 21:1165-1175.
74. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005, 113:823-839.
75. 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryngologica 1970, 70:58-61.
76. Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res 2010, 70:6303-6312.
77. Corem-Salkmon E, Ram Z, Daniels D, Perlstein B, Last D, Salomon S, Tamar G, Shneor R, Guez D, Margel S, et al. Convection-enhanced delivery of methotrexate-loaded maghemite nanoparticles. Int J Nanomed 2011, 6:1595-1602.
78. Daneshvar H, Nelms J, Muhammad O, Jackson H, Tkach J, Davros W, Peterson T, Vogelbaum MA, Bruchez MP, Toms SA. Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots. Nanomedicine (Lond) 2008, 3:21-29.
79. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003, 422:37-44.
80. Xu J, Ling EA. Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. J Anat 1994, 184 (Pt 2):227-237.
81. Yokel RA. Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration. J Alzheimer's Dis 2006, 10:223-253.
82. Kato S, Itoh K, Yaoi T, Tozawa T, Yoshikawa Y, Yasui H, Kanamura N, Hoshino A, Manabe N, Yamamoto K, et al. Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain. Nanotechnology 2010. doi:21:335103/1-335103/7.
83. Chithrani BD, Chan WC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 2007, 7:1542-1550.
84. AshaRani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol 2009, 10:65.
85. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small 2011, 7:3341-3349.
86. Shi X, von dem Bussche A, Hurt RH, Kane AB, Gao H. Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat Nanotechnol 2011, 6:714-719.
87. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29:1912-1919.
88. Sonavane G, Tomoda K, Makino K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 2008, 66:274-280.
89. Terentyuk GS, Maslyakova GN, Suleymanova LV, Khlebtsov BN, Kogan BY, Akchurin GG, Shantrocha AV, Maksimova IL, Khlebtsov NG, Tuchin VV. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J Biophotonics 2009, 2:292-302.
90. Balogh L, Nigavekar SS, Nair BM, Lesniak W, Zhang C, Sung LY, Kariapper MS, El-Jawahri A, Llanes M, Bolton B, et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine 2007, 3:281-296.
91. Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr. et al. Brain microvessel endothelial cells responses to gold nanoparticles: In vitro pro-inflammatory mediators and permeability. Nanotoxicology 2011, 5:479-492.
92. Etame AB, Smith CA, Chan WCW, Rutka JT. Design and potential application of PEGylated gold nanoparticles with size-dependent permeation through brain microvasculature. Nanomedicine 2011, 7:992-1000.
93. Kim JH, Kim JH, Kim KW, Kim MH, Yu YS. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechnology 2009, 20:505101.
94. Jo DH, Lee TG, Kim JH. Nanotechnology and nanotoxicology in retinopathy. Int J Mol Sci 2011, 12:8288-8301.
95. Chen Y-S, Hung Y-C, Lin L-W, Liau I, Hong M-Y, Huang GS. Size-dependent impairment of cognition in mice caused by the injection of gold nanoparticles. Nanotechnology 2010. doi:21:485102/1-485102/9.
96. Schleh C, Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schaeffler M, Schmid G, Simon U, Kreyling WG. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012, 6:36-46.
97. Hirn S, Semmler-Behnke M, Schleh C, Wenk A, Lipka J, Schaffler M, Takenaka S, Moller W, Schmid G, Simon U, et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. Eur J Pharm Biopharm 2011, 77:407-416.
98. Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 2009, 8:543-557.
99. Auffan M, Rose J, Bottero J-Y, Lowry GV, Jolivet J-P, Wiesner MR. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat Nanotechnol 2009, 4:634-641.
100. Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, Douglas JF. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 2010, 4:365-379.
101. Fenart L, Casanova A, Dehouck B, Duhem C, Slupek S, Cecchelli R, Betbeder D. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. J Pharmacol Exp Ther 1999, 291:1017-1022.
102. Jallouli Y, Paillard A, Chang J, Sevin E, Betbeder D. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Int J Pharm 2007, 344:103-109.
103. Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004, 12:635-641.
104. Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RR. Etoposide-incorporated tripalmitin nanoparticles with different surface charge: Formulation, characterization, radiolabeling, and biodistribution studies. AAPS J 2004, 6:55-64.
105. Guerrero S, Araya E, Fiedler JL, Arias JI, Adura C, Albericio F, Giralt E, Arias JL, Fernandez MS, Kogan MJ. Improving the brain delivery of gold nanoparticles by conjugation with an amphipathic peptide. Nanomedicine (Lond) 2010, 5:897-913.
106. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson KS, Roel Stone V, Kreyling W, Lademann J, et al. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006, 3:35.
107. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell "sees" in bionanoscience. J Am Chem Soc 2010, 132:5761-5768.
108. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011, 133:2525-2534.
109. Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fifield LS, Jacobs JM, Addleman SR, Kaysen GA, Moudgil BM, Weber TJ. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 2007, 100:303-315.
110. Horie M, Nishio K, Fujita K, Endoh S, Miyauchi A, Saito Y, Iwahashi H, Yamamoto K, Murayama H, Nakano H, et al. Protein adsorption of ultrafine metal oxide and its Influence on cytotoxicity toward cultured cells. Chem Res Toxicol 2009, 22:543-553.
111. Kreuter J. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 2004, 4:484-488.
112. Brown DM, Wilson MR, MacNee W, Stone V, Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol Appl Pharmacol 2001, 175:191-199.
113. Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJ. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol 2007, 49:217-229.
114. Foster KA, Yazdanian M, Audus KL. Microparticulate uptake mechanisms of in-vitro cell culture models of the respiratory epithelium. J Pharm Pharmacol 2001, 53:57-66.
115. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009. doi:20:455101/1-455101/9.
116. Lovric J, Bazzi HS, Cuie Y, Fortin GR, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. J Mol Med 2005, 83:377-385.
117. Maysinger D, Behrendt M, Lalancette-Hebert M, Kriz J. Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles. Nano Lett 2007, 7:2513-2520.
118. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 2006, 40:4346-4352.
119. Haase A, Rott S, Mantion A, Graf P, Plendl J, Thunemann AF, Meier WP, Taubert A, Luch A, Reiser G. Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses. Toxicol Sci 2012, 126:457-468.
120. Sharma HS, Sharma A. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog Brain Res 2007, 162:245-273.
121. Sharma HS, Ali SF, Hussain SM, Schlager JJ, Sharma A. Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J Nanosci Nanotechnol 2009, 9:5055-5072.
122. Sharma HS, Ali SF, Tian ZR, Hussain SM, Schlager JJ, Sjoquist PO, Sharma A, Muresanu DF. Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. J Nanosci Nanotechnol 2009, 9:5073-5090.
123. Mejias R, Perez-Yague S, Roca AG, Perez N, Villanueva A, Canete M, Manes S, Ruiz-Cabello J, Benito M, Labarta A, et al. Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles. Nanomedicine (Lond) 2010, 5:397-408.
124. Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, Lee KH, Park SB, Lee JK, Cho MH. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 2006, 89:338-347.
125. Yokel RA, Florence RL, Unrine JM, Tseng MT, Graham UM, Wu P, Grulke EA, Sultana R, Hardas SS, Butterfield DA. Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial. Nanotoxicology 2009, 3:234-248.
126. Hardas SS, Butterfield DA, Sultana R, Tseng MT, Dan M, Florence RL, Unrine JM, Graham UM, Wu P, Grulke EA, et al. Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria. Toxicol Sci 2010, 116:562-576.
127. Chen L, Yokel RA, Hennig B, Toborek M. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol 2008, 3:286-295.
128. 2 nanoparticles. Biomaterials 2012, 33:886-896.
129. Trickler WJ, Lantz SM, Murdock RC, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Oldenburg SJ, Paule MG, Slikker W Jr. et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci 2010, 118:160-170.
130. Trickler WJ, Lantz SM, Schrand AM, Robinson BL, Newport GD, Schlager JJ, Paule MG, Slikker W, Biris AS, Hussain SM, et al. Effects of copper nanoparticles on rat cerebral microvessel endothelial cells. Nanomedicine (Lond) 2012, 7:835-846.
131. Wang J, Zhou G, Chen C, Yu H, Wang T, Ma Y, Jia G, Gao Y, Li B, Sun J, et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol Lett 2007, 168:176-185.
132. 2 delivered to the abdominal cavity. Biomaterials 2010, 31:99-105.
133. 2 nanoparticles. Biomaterials 2010, 31:8043-8050.
134. Shin JA, Lee EJ, Seo SM, Kim HS, Kang JL, Park EM. Nanosized titanium dioxide enhanced inflammatory responses in the septic brain of mouse. Neuroscience 2010, 165:445-454.
135. Lee H-Y, Choi Y-J, Jung E-J, Yin H-Q, Kwon J-T, Kim J-E, Im H-T, Cho M-H, Kim J-H, Kim H-Y, et al. Genomics-based screening of differentially expressed genes in the brains of mice exposed to silver nanoparticles via inhalation. J Nanopart Res 2010, 12:1567-1578.
136. Campbell A, Oldham M, Becaria A, Bondy SC, Meacher D, Sioutas C, Misra C, Mendez LB, Kleinman M. Particulate matter in polluted air may increase biomarkers of inflammation in mouse brain. Neurotoxicology 2005, 26:133-140.
137. Utell MJ, Frampton MW, Zareba W, Devlin RB, Cascio WE. Cardiovascular effects associated with air pollution: potential mechanisms and methods of testing. Inhal Toxicol 2002, 14:1231-1247.
138. Bhabra G, Sood A, Fisher B, Cartwright L, Saunders M, Evans WH, Surprenant A, Lopez-Castejon G, Mann S, Davis SA, et al. Nanoparticles can cause DNA damage across a cellular barrier. Nat Nanotechnol 2009, 4:876-883.
139. Xu R, Ma J, Sun X, Chen Z, Jiang X, Guo Z, Huang L, Li Y, Wang M, Wang C, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res 2009, 19:1031-1034.
140. Pompa PP, Vecchio G, Galeone A, Brunetti V, Maiorano G, Sabella S, Cingolani R. Physical assessment of toxicology at nanoscale: nano dose-metrics and toxicity factor. Nanoscale 2011, 3:2889-2897.
141. Vecchio G, Galeone A, Brunetti V, Maiorano G, Sabella S, Cingolani R, Pompa PP. Concentration-dependent, size-independent toxicity of citrate capped AuNPs in Drosophila melanogaster. PLoS One 2012, 7:e29980.
142. Wang H-J, Yang L, Yang H-Y, Wang K, Yao W-G, Jiang K, Huang X-L, Zheng Z. Antineoplastic activities of protein-conjugated silver sulfide nano-crystals with different shapes. J Inorg Biochem 2010, 104:87-91.
143. Tarantola M, Pietuch A, Schneider D, Rother J, Sunnick E, Rosman C, Pierrat S, Sonnichsen C, Wegener J, Janshoff A. Toxicity of gold-nanoparticles: synergistic effects of shape and surface functionalization on micromotility of epithelial cells. Nanotoxicology 2011, 5:254-268.
144. Mahto SK, Yoon TH, Rhee SW. Cytotoxic effects of surface-modified quantum dots on neuron-like PC12 cells cultured inside microfluidic devices. BioChip J 2010, 4:82-88.
145. Soenen SJH, Himmelreich U, Nuytten N, Pisanic IITR, Ferrari A, De CM. Intracellular nanoparticle coating stability determines nanoparticle diagnostics efficacy and cell functionality. Small 2010, 6:2136-2145.
146. Soenen SJH, Himmelreich U, Nuytten N, De CM. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labeling. Biomaterials 2010, 32:195-205.
147. Rivet CJ, Yuan Y, Borca-Tasciuc D-A, Gilbert RJ, Altering iron. oxide nanoparticle surface properties induce cortical neuron cytotoxicity. Chem Res Toxicol 2012, 25:153-161.
148. 2 nanoparticles as a function of crystal phase, surface area and coating, in relation to their potential toxicity in peripheral nervous system. J Colloid Interface Sci 2012, 369:28-39.
149. Phenrat T, Long TC, Lowry GV, Veronesi B. Partial oxidation ("aging") and surface modification decrease the toxicity of nanosized zerovalent iron. Environ Sci Technol 2009, 43:195-200.
150. Cui B, Wu C, Chen L, Ramirez A, Bearer EL, Li W-P, Mobley WC, Chu S. One at a time, live tracking of NGF axonal transport using quantum dots. Proc Natl Acad Sci U S A 2007, 104:13666-13671.
151. Jain MP, Choi AO, Neibert KD, Maysinger D. Probing and preventing quantum dot-induced cytotoxicity with multimodal alpha-lipoic acid in multiple dimensions of the peripheral nervous system. Nanomedicine (Lond) 2009, 4:277-290.
152. Jaiswal AR, Lu S, Pfau J, Wong YYW, Bhushan A, Leung SW, Daniels CK, Lai JCK. Effects of silicon dioxide nanoparticles on peripheral nervous system neural cell models. In: Laudon M, Romanowicz B, eds. Nanotech Conference & Expo 2011: An Interdisciplinary Integrative Forum on Nanotechnology, Biotechnology and Microtechnology. Boston, MA: CRC Press; 2011, 541-544.
153. Oszlanczi G, Papp A, Szaboo A, Nagymajtenyi L, Sapi A, Konya Z, Paulik E, Vezer T. Nervous system effects in rats on subacute exposure by lead-containing nanoparticles via the airways. Inhal Toxicol 2011, 23:173-181.
154. Lu S, Jaiswal AR, Wong YYW, Bhushan A, Leung SW, Daniels CK, Lai JCK. Differential cytotoxic effects of titanium oxide nanoparticles on peripheral nervous system neural cells. Nanotech Conference & Expo 2011: An Interdisciplinary Integrative Forum on Nanotechnology, Biotechnology and Microtechnology. Boston, MA: CRC Press; 2011.
155. Menon PK, Muresanu DF, Sharma A, Moessler H, Sharma HS. Cerebrolysin, a mixture of neurotrophic factors induces marked neuroprotection in spinal cord injury following intoxication of engineered nanoparticles from metals. CNS Neurol Disord: Drug Targets 2012, 11:40-49.
156. Sharma HS, Sharma A. Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, 4:184-203.
157. Lin Y-L, Jen J-C, Hsu S-h, Chiu I-M. Sciatic nerve repair by microgrooved nerve conduits made of chitosan-gold nanocomposites. Surg Neurol 2008, 70(suppl 1):9-18.
158. Das M, Patil S, Bhargava N, Kang JF, Riedel LM, Seal S, Hickman JJ. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28:1918-1925.
159. Cannon JR, Greenamyre JT. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci 2011, 124:225-250.
160. Geppert M, Hohnholt MC, Thiel K, Nuernberger S, Grunwald I, Rezwan K, Dringen R. Uptake of dimercaptosuccinate-coated magnetic iron oxide nanoparticles by cultured brain astrocytes. Nanotechnology 2011. doi:22:145101/1-145101/10.
161. 4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies. Pharm Res 2012, 29:1328-1343.
162. Long TC, Tajuba J, Sama P, Saleh N, Swartz C, Parker J, Hester S, Lowry GV, Veronesi B. Nanosize titanium dioxide stimulates reactive oxygen species in brain microglia and damages neurons in vitro. Environ Health Perspect 2007, 115:1631-1637.
163. Przybytkowski E, Behrendt M, Dubois D, Maysinger D. Nanoparticles can induce changes in the intracellular metabolism of lipids without compromising cellular viability. FEBS J 2009, 276:6204-6217.
164. Chan WH, Shiao NH, Lu PZ. CdSe quantum dots induce apoptosis in human neuroblastoma cells via mitochondrial-dependent pathways and inhibition of survival signals. Toxicol Lett 2006, 167:191-200.
165. Choi AO, Cho SJ, Desbarats J, Lovric J, Maysinger D. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnol 2007, 5:1.
166. Tang M, Xing T, Zeng J, Wang H, Li C, Yin S, Yan D, Deng H, Liu J, Wang M, et al. Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons. Environ Health Perspect 2008, 116:915-922.
167. Lai JCK, Lai MB, Jandhyam S, Dukhande VV, Bhushan A, Daniels CK, Leung SW. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. Int J Nanomed 2008, 3:533-545.
168. Pinkernelle J, Calatayud P, Goya GF, Fansa H, Keilhoff G. Magnetic nanoparticles in primary neural cell cultures are mainly taken up by microglia. BMC Neurosci 2012, 13:32.
169. Zeng G, Wang G, Guan F, Chang K, Jiao H, Gao W, Xi S, Yang B. Human amniotic membrane-derived mesenchymal stem cells labeled with superparamagnetic iron oxide nanoparticles: the effect on neuron-like differentiation in vitro. Mol Cell Biochem 2011, 357:331-341.
170. Asharani PV, Wu YL, Gong Z, Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008. doi:19:255102/1-255102/8.
171. Jovanovic B, Ji T, Palic D. Gene expression of zebrafish embryos exposed to titanium dioxide nanoparticles and hydroxylated fullerenes. Ecotoxicol Environ Saf 2011, 74:1518-1525.
172. Chen J, Dong X, Xin Y, Zhao M. Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure. Aquat Toxicol 2011, 101:493-499.
173. Palaniappan PR, Pramod KS. The effect of titanium dioxide on the biochemical constituents of the brain of Zebrafish (Danio rerio): an FT-IR study. Spectrochim Acta, Part A 2011, 79:206-212.
174. Truong L, Tilton S, Zaikov T, Richman E, Waters KH, Hutchison JE, Tanguay R. Surface functionalities of gold nanoparticles impact embryonic gene expression responses. Nanotoxicology (Epub ahead of print; January 20, 2012). Available at: http://informahea lthcare.com/doi/pdf/10.3109/17435390.2011.648225. (Accessed December 6, 2012).
175. Chen T-H, Lin C-Y, Tseng M-C. Behavioral effects of titanium dioxide nanoparticles on larval zebrafish (Danio rerio). Mar Pollut Bull 2011, 63:303-308.
176. 2 exhibits adverse effects at environmental relevant concentrations. Environ Sci Technol 2011, 45:3725-3730.
177. Ma H, Bertsch PM, Glenn TC, Kabengi NJ, Williams PL. Toxicity of manufactured zinc oxide nanoparticles in the nematode Caenorhabditis elegans. EnvironToxicol Chem 2009, 28:1324-1330.
178. Choi CH, Alabi CA, Webster P, Davis ME. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci U S A 2010, 107: 1235-1240.
179. Kim YH, Jeon J, Hong SH, Rhim WK, Lee YS, Youn H, Chung JK, Lee MC, Lee DS, Kang KW, et al. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small 2011, 7:2052-2060.
180. Cheng Y, Meyers JD, Agnes RS, Doane TL, Kenney ME, Broome A-M, Burda C, Basilion JP. Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? Small 2011, 7:2301-2306.
181. Dhar S, Reddy EM, Prabhune A, Pokharkar V, Shiras A, Prasad BL. Cytotoxicity of sophorolipid-gellan gum-gold nanoparticle conjugates and their doxorubicin loaded derivatives towards human glioma and human glioma stem cell lines. Nanoscale 2011, 3:575-580.
182. Ip S, MacLaughlin CM, Gunari N, Walker GC. Phospholipid membrane encapsulation of nanoparticles for surface-enhanced Raman scattering. Langmuir 2011, 27:7024-7033.
183. Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, Olmedo I, Clos A, Sadagopa Ramanujam VM, Urayama A, Vergara L, Kogan MJ, Soto C. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Biophys Res Commun 2010, 393:649-655.
184. Cho WS, Cho M, Jeong J, Choi M, Cho HY, Han BS, Kim SH, Kim HO, Lim YT, Chung BH. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 2009, 236:16-24.
185. dos Santos Silva I, Malveiro F, Jones ME, Swerdlow AJ. Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal. Radiat Res 2003, 159:521-534.
186. Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B. Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 2008, 82:151-157.
187. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjug Chem 2004, 15:79-86.
188. Bonoiu AC, Bergey EJ, Ding H, Hu R, Kumar R, Yong KT, Prasad PN, Mahajan S, Picchione KE, Bhattacharjee A, et al. Gold nanorod-siRNA induces efficient in vivo gene silencing in the rat hippocampus. Nanomedicine (Lond) 2011, 6:617-630.
189. Sabella S, Galeone A, Vecchio G, Cingolani R, Pompa PP. AuNPs are toxic in vitro and in vivo: a review. J Nanosci Lett 2011, 1:145-165.
190. Khlebtsov N, Dykman L. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 2011, 40:1647-1671.
191. Sperling RA, Rivera GP, Zhang F, Zanella M, Parak WJ. Biological applications of gold nanoparticles. Chem Soc Rev 2008, 37:1896-1908.
192. Brown CL, Whitehouse MW, Tiekink ER, Bushell GR. Colloidal metallic gold is not bio-inert. Inflammopharmacology 2008, 16:133-137.
193. Chen Y-S, Hung Y-C, Liau I, Huang GS. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Res Lett 2009, 4:858-864.
194. Hayashi A, Naseri A, Pennesi ME, Juan E. Subretinal delivery of immunoglobulin G with gold nanoparticles in the rabbit eye. Jpn J Ophthalmol 2009, 53:249-256.
195. Rocha A, Zhou Y, Kundu S, Gonzalez JM, BradleighVinson S, Liang H. In vivo observation of gold nanoparticles in the central nervous system of Blaberus discoidalis. J Nanobiotechnology 2011, 9:9.
196. Park E-JC, Wan-Seob Jeong J, Yi J-h, Choi K, Kim Y, Park K. Induction of inflammatory responses in mice treated with cerium oxide nanoparticles by intratracheal instillation. J Health Sci 2010, 56:387-396.